The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 16 July 2001. doi:10.1084/jem.194.2.173
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 115K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sano, G.-i.
Right arrow Articles by Zavala, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sano, G.-i.
Right arrow Articles by Zavala, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/7/173/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 2, July 16, 2001 173-180


Original Article

Swift Development of Protective Effector Functions in Naive CD8+ T Cells Against Malaria Liver Stages

Gen-ichiro Sanoa, Julius C.R. Hafallaa, Alexandre Morrota, Ryo Abeb, Juan J. Lafaillec, and Fidel Zavalaa
a Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, NY 10010
b Division of Immunology, Research Institutes of Biological Sciences, Science University of Tokyo, Chiba 278-0022, Japan
c Molecular Pathogenesis Program, Skirball Institute, New York University School of Medicine, New York, NY 10016

Correspondence to: Fidel Zavala, Department of Medical and Molecular Parasitology, New York University School of Medicine, 341 E. 25th St., New York, NY 10010. Tel:212-263-6757 Fax:212-263-8116 E-mail:fz5{at}nyu.edu.

We generated T cell receptor transgenic mice specific for the liver stages of the rodent malaria parasite Plasmodium yoelii and studied the early events in the development of in vivo effector functions in antigen-specific CD8+ T cells. Differently to activated/memory cells, naive CD8+ T cells are not capable of exerting antiparasitic activity unless previously primed by parasite immunization. While naive cells need to differentiate before achieving effector status, the time required for this process is very short. Indeed, interferon (IFN)-{gamma} and perforin mRNA are detectable 24 h after immunization and IFN-{gamma} secretion and cytotoxic activity are detected ex vivo 24 and 48 h after immunization, respectively. In contrast, the proliferation of CD8+ T cells begins after 24 h and an increase in the total number of antigen-specific cells is detected only after 48 h. Remarkably, a strong CD8+ T cell–mediated inhibition of parasite development is observed in mice challenged with viable parasites only 24 h after immunization with attenuated parasites. These results indicate that differentiation of naive CD8+ T cells does not begin only after extensive cell division, rather this process precedes or occurs simultaneously with proliferation.

Key Words: malaria, CD8+ T cells, TCR transgenic mouse, effector T cell, in vivo differentiation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS